TCBIO
TEXAS CAPITAL BANCSHARES INC/TX
NASDAQ · Financial Services · Banks - Regional · US
$18.28
+0.00%Year over year
Reported trailing growth
- Revenue
- -6.1%
- EBITDA
- -20.9%
- EBIT
- -14.0%
- EPS
- +28.4%
- Free cash flow
- +142.7%
- Operating cash flow
- +117.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.9%
- EBITDA
- +0.5%
- EBIT
- +5.4%
- Net income
- -0.2%
- EPS
- +3.2%
- Free cash flow
- +37.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026